Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) have been given a consensus recommendation of “Moderate Buy” by the nine research firms that are covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating, three have issued a buy rating and two have given a strong buy rating to the company.

RBGLY has been the subject of several analyst reports. BNP Paribas Exane cut shares of Reckitt Benckiser Group from an “outperform” rating to a “neutral” rating in a report on Wednesday, September 2nd. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Reckitt Benckiser Group in a report on Tuesday, June 30th. Jefferies Financial Group upgraded Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research report on Tuesday, July 21st. Finally, Zacks Research upgraded shares of Reckitt Benckiser Group from a “strong sell” rating to a “hold” rating in a research report on Friday, August 28th.

Reckitt Benckiser Group Price Performance

OTCMKTS:RBGLY opened at $13.30 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.63 and a debt-to-equity ratio of 0.98. The firm’s fifty day moving average price is $13.90 and its 200 day moving average price is $13.55. Reckitt Benckiser Group has a 1-year low of $12.02 and a 1-year high of $17.80.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc, operating under the Reckitt name, is a global consumer health and hygiene company headquartered in Slough, England. The company develops, manufactures and markets products intended to support personal health, household hygiene and nutrition, selling through retailers, pharmacies and e-commerce channels.

Its portfolio includes well-known brands such as Dettol and Lysol in hygiene; Durex in sexual wellness; Nurofen, Strepsils and Mucinex in consumer health; and Finish in dishwashing products.